Skip to Content
U.S. National Institutes of Health
Last Updated: 11/28/13

Breast SPOREs

Breast cancer is one of the most common forms of cancer diagnosed in women in the United States and is second only to lung cancer in cancer deaths. As estimated by the American Cancer Society, approximately 232,340 new invasive breast cancer cases will be identified in women in 2013 and about 39,620 deaths will be attributed to this disease. During the course of her lifetime, a woman has a one in eight chance of developing breast cancer. Much progress has been made over the past decade in identifying hereditary factors, as well as novel therapeutic and preventative agents for breast cancer. The Breast Cancer SPORE program has evolved significantly from 1992, when four sites were funded. Current grants support development of novel agents (small molecule inhibitors, anti-estrogens, vaccines and antibodies), technologies (microarrays, genomic sequencing, quantitative proteomics, mass spectrometry), and markers (i.e. cancer-related genes/proteins) for better diagnosis, prognosis, screening, prevention, and treatment of breast cancer.

Baylor College of Medicine

C. Kent Osborne, MD [Click Here]
Baylor College of Medicine
One Baylor Plaza, BCM 600
Houston, TX 77030
Tel: (713) 798-1600
Fax: (713) 798-1642
Email: kosborne@bcm.edu

For more information on this specific SPORE’s institution, please visit:
http://www.bcm.edu/breastcenter/index.cfm?PMID=0

Dana-Farber Harvard Cancer Institute

Eric Winer, MD [Click Here]
Dana-Farber Cancer Institute
Department of Medical Oncology
Division of Women’s Cancers
450 Brookline Avenue, Boston, MA 02215
Tel: (617) 632-2261
Fax: (617) 632-1930
Email: ewiner@partners.org

For more information on this specific SPORE?s institution, please visit:
http://dfhcc.harvard.edu/spores/breast/
http://trp.cancer.gov/spores/abstracts/dfhcc_breast.htm

Fred Hutchinson Cancer Research Center

Peggy Porter, MD [Click Here]
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North
PO Box 19024, C1-015
Seattle, WA 98109-1024
Tel: (206) 667-3751
Fax: (206) 667-7264
Email: pporter@fhcrc.org

For more information on this specific SPORE’s institution, please visit:
http://www.fhcrc.org/en/labs/science-projects/breast-cancer-program/seattle-cancer-consortium-breast-spore.html

Mayo Clinic, Rochester

James N. Ingle, MD [Click Here]
Co-Director, Women’s Cancer Program
Mayo Clinic and Foundation
Department of Oncology
Mayo Clinic College of Medicine
200 First Street Southwest
Rochester, MN 55905
Tel: (507) 284-8432
Fax: (507) 538-0823
Email: ingle.james@mayo.edu

For more information on this specific SPORE’s institution, please visit:
http://cancercenter.mayo.edu/mayo/research/womens_cancer/spore_grant.cfm

University of North Carolina at Chapel Hill

H. Shelton Earp, III, MD [Click Here]
University of North Carolina at Chapel Hill
Department of Medicine
Campus Box 7295, Rm. 10-012
Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina 27599
Tel: (919) 966-2335
Fax: (919) 966-3015
Email: hse@med.unc.edu

For more information on this specific SPORE’s institution, please visit:
http://cancer.med.unc.edu/research/spore.asp

Vanderbilt University

Carlos Arteaga, MD [Click Here]
Vanderbilt University Medical Center
Vanderbilt-Ingram University Cancer Center
Department of Medicine
2200 Pierce Avenue
777 Preston Research Building
Nashville, TN 37232
Tel: (615) 936-3524
Fax: (615) 936-1790
Email: carlos.arteaga@vanderbilt.edu

For more information on this specific SPORE’s institution, please visit:
http://www.vicc.org/spores/breast/